Latest filing published 24 May 2024 for Esperion Therapeutics, Inc..
No signal scores available.
Antonio M. Jr Md D. Phil Gotto (board member) discloses dealings in 3 companies, chiefly Esperion Therapeutics, Inc., Aegerion Pharmaceuticals, Inc. and Medtronic Inc. Between 24 August 2006 and 23 May 2024, the trades on record add up to 7 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 24 May 2024 with a share grant in Esperion Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations